Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 3 Waldenstrom Macroglobulinemia 1 Stomach Neoplasms 1 Recurrence 1 Neoplasms, Second Primary 1 Neoplasms 1 NSCLC 1 Lymphoma, Mantle-Cell 1 Immunoglobulin Light-chain Amyloidosis 1

Interventions

Bismuth 6 Esomeprazole 5 Amoxicillin 5 Tetracycline 4 Oxaliplatin 4 apatinib 3 Irinotecan 3 Furazolidone 3 Fluorouracil 3 Clarithromycin 3 fish oil triglycerides 2 Rabeprazole 2 Leucovorin 2 Indocyanine Green 2 Berberine 2 sintilimab 1 potassium oxonate 1 lenvatinib 1 iron isomaltoside 1000 1 ilaprazole 1 gimeracil 1 ferric carboxymaltose 1 doxifluridine 1 alanylglutamine 1 Water 1 Trastuzumab 1 Tranexamic Acid 1 Tobacco Use Cessation Devices 1 Thalidomide 1 Tegafur 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Stomach Neoplasms × Thalidomide × Clear all

NCT02401971 2015-03-30

ITAGC

Zhengzhou University

Phase 4 Unknown

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡